Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

‘Like shipping ice cubes in the desert’: How Boston Scientific handles the supply chain challenges of radioactive TheraSphere devices

July 1, 2024 By Jim Hammerand

A photo showing the inside of the Missouri University Research Reactor (MURR).

The Missouri University Research Reactor (MURR) is the highest-power university research reactor in the U.S. It’s one of the sites where Boston Scientific’s TheraSpheres get their radioactivity. [Photo courtesy of the University of Missouri]

The clock starts ticking when Boston Scientific‘s TheraSpheres exit the nuclear reactors where they get their cancer-killing radioactivity.

That radioactive power immediately begins to wane due to the half life of yttrium-90, the beta-radiation-emitting isotope in the a glass beads that slow or halt the growth of liver cancer tumors.

“As soon as they come out [of the reactor] they’re starting to decay,” Boston Scientific Interventional Oncology President Peter Pattison said in an interview.

“It’s like we’re shipping ice cubes in the desert,” he continued. “… You have to have a good process.”

DeviceTalks Minnesota: Learn more from Boston Scientific Interventional Oncology at our Minneapolis show on June 11, 2025

Pattison — who previously explained to Medical Design & Outsourcing readers how Boston Scientific’s TheraSphere devices work, how they’re manufactured and what other cancers they might be able to treat — discussed the logistics and supply chain challenges posed by this radioactive medtech.

Nuclear reactors in the supply chain

A photo of MURR staff using the research reactor to create radioactive isotopes.

MURR staff using the research reactor to create radioactive isotopes. [Photo courtesy of the University of Missouri]

After the inert TheraSphere glass beads are made, Boston Scientific partners with government-run research reactors to bombard the microscopic devices with neutrons to make them radioactive.

Boston Scientific’s global network of reactors include the Missouri University Research Reactor (MURR), the Petten High Flux Reactor in the Netherlands, and reactors in Australia, Belgium, Poland and South Africa.

“These are very big, very complicated, very regulated facilities. As a result, they will go down for maintenance. Usually it’s planned maintenance, but sometimes something’s come up and they need to shut it down and do a safety check,” Pattison said.

“For us, it’s important to have a network so if we know that a reactor will go down for the next two months, that’s OK because we have four or five other reactors or more that we can draw from. It requires a lot of hand-holding from our supply chain group,” he continued.

“The most fascinating part of the process”

A photo of a BWXT Medical employee in protective gear dispensing radioactive TheraSphere beads inside a shielded "hot cell" using manual manipulators.

Employees at contract manufacturer BWXT Medical dispense radioactive TheraSphere beads inside a shielded “hot cell” using manual manipulators. [Photo courtesy of BWXT Medical]

All of the irradiated TheraSpheres then go to Boston Scientific’s dispensing contractor, BWXT Medical, in Ottawa, Ontario. There, BWXT employees dispense and package the radioactive glass beads behind a protective layer of lead glass.

Each dose is packaged in a 100-microliter glass vial with a Lucite shield. (Lucite is a brand name for polymethyl methacrylate, a synthetic polymer also called PMMA.) The vial and shield are packaged in a lead container to block all beta radiation, and then that’s packaged in styrofoam and a bright yellow cardboard box measuring about one cubic foot.

The dispensing employees use manual manipulators rather than electronic systems that would malfunction inside the “hot cell” due to the radiation.

A photo of a BWXT Medical employee dispensing Boston Scientific TheraSpheres inside a hot cell at the BWXT dispensing facility in Ottawa, Ontario.

A look inside a “hot cell” at the BWXT dispensing facility in Ottawa, Ontario [Photo courtesy of BWXT Medical]

“These very skilled operators are able to open vials, dispense, close vials, move things in and out … remotely with these very sensitive, manual and non-electronic, non-automated manipulators,” Pattison said. “… Our contract manufacturer that does the actual dispensing is probably the most fascinating part of the process.”

Shipping radioactive devices

Boston Scientific aims for the dose to reach the interventional radiologist within two to three days, but can get it to them the next day in an emergency.

“Our ability to move in a timely fashion is world-class,” Pattison said. “We’ve had to charter aircraft at the last minute, we’ve had to send people in trucks to go get things. The hero stories — I don’t love when they happen, but I love that they turn out the right way.”

The company uses couriers rather than owning or leasing its own fleet of aircraft or delivery vehicles. To make the shipments easier for couriers to spot if they go missing in a warehouse, Boston Scientific picked a “super-bright, obnoxious” yellow color for the cardboard boxes.

“Having these bright yellow boxes for the couriers is something that’s proved to be quite helpful to us,” he said.

A portrait of Boston Scientific Interventional Oncology President Peter Pattison.

Boston Scientific Interventional Oncology President Peter Pattison [Photo courtesy of Boston Scientific]

Based on how much radiation is needed for a patient (measured in a unit known as the becquerel, abbreviated Bq) and when the procedure is scheduled to take place, Boston Scientific works out the transit time from Ottawa, the becquerel needed to arrive with just the right dose, and the chain of custody along the way.

“We just want the customer to worry about the dose and the day and where they are,” Pattison said. “We’ll figure out the rest of that supply chain, work back from the last-mile courier to maybe the trucking company to maybe the airline. It’s really quite astounding the detail that’s required to make sure all these packages get around the world every day.”

You may also like:

  • An illustration of Therasphere delivering radiation to a tumor.
    Boston Scientific’s microscopic TheraSphere devices go from nuclear reactors to…
  • A photo of the Boston Scientific Farapulse pulsed field ablation system's Farawave catheter.
    Catheter design was key for the Boston Scientific Farapulse pulsed…
  • An illustration of Boston Scientific's plans for a new campus in Maple Grove, Minnesota.
    Boston Scientific wins public funding for $170M ‘Project Black Bear’…
  • An illustration of the Boston Scientific's EkoSonic Endovascular System (EKOS).
    RWE tips from Boston Scientific Peripheral Interventions CMO Dr. Michael…

About The Author

Jim Hammerand

Jim Hammerand is the managing editor of Arrowfly's Medical Design & Outsourcing, where he leads coverage of medtech innovation, design, engineering and manufacturing. He also reports breaking news at Arrowfly's MassDevice and contributes to our DeviceTalks podcasts and live events. Hammerand has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then as managing editor of the Puget Sound Business Journal in Seattle. He holds degrees in journalism and management from the University of Minnesota and has won journalism awards from the Society of Professional Journalists, American Society of Business Publication Editors, and Trade, Association, Business Publications International. Connect with him on LinkedIn or by email at [email protected].

Related Articles Read More >

An illustration of HITMAN operating in glioblastoma cells.
MIT researchers develop injectable nanodevices that remotely kill brain tumor cells
Researchers test electroporation to advance CAR T-cell therapy
Image courtesy of NIH, iStock, MIT News
Researchers release hundreds of cancer models to develop new treatments
A photo of University of Massachusetts Amherst researchers Stephanie Hallerman and Neeraj Raghuraman, who are working on ablation technology to prevent bladder cancer recurrence.
Researchers are reworking an ablation technique to develop a novel cancer treatment
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe